Categoría

Europ. Associat. for the Study of the Liver

Home > Comunicaciones y Congresos > Europ. Associat. for the Study of the Liver

Camelo Castillo A, Romero Portales M, Vargas-Accarino E, García-Retortillo M, El Hajra Martínez I, Fernández Vázquez I, López Jardiel J, Rendón P, Molina Pérez E, González-Grande R, Menacho S, Romero Herrera G, Cuesta Cortijo R, Simón MA, Narváez Rodríguez I, Montero Álvarez JL, González Santiago JM, Albertos Rubio S, Freyre Carrillo C, Sansó Sureda A, Vinaixa C, Rodríguez Marcos E, Alejandre Altamirano RM, Zacarías Martínez L, Aller de La Fuente R, Blanco Cano S, González de Adalid C, Espinoza-Cámac N, Domínguez-Hernández R, Casado Martín M

Implementation of the ReLink-C strategy in hospitals in Spain (ReLink-C Observatory Spain)
EASL Congress 2026. Barcelona. 27 al 30 de may 2026

García Herola A, Pascual S, Cuesta R, Mármol-Aguilar C, Bejarano A, Díaz A, Millán M, Méndez M, Domínguez-Hernández R

 
 

HCV screening automation at hospitals level based on Extrahepatic Manifestations and Risk Profile. Preliminary results from the Hospitals Without_ C programme (Hospitales sin C)
International Liver Congress (EASL). Viena. 21-24 jun 2023

Buti M, Calleja JL, Rodríguez MÁ, Cantero H, de las Heras A, Domínguez-Hernández R, Casado MÁ

 

 

Bulevirtide avoids future clinical events and related costs compared to pegylated-interferon alpha in chronic hepatitis D in Spain
International Liver Congress (EASL). London. 22-26 jun 2022

Esteban R, Domínguez-Hernández R, Cantero H, Casado MA

 

 

Evaluation of the clinical and economic value of sofosbuvir / velpatasvir (SOF / VEL) in patients with chronic hepatitis C in Spain during the last 5 years
International Liver Congress (EASL). London. 22-26 jun 2022

Esteban R, Domínguez-Hernández R, Casado MA

 

 

 

Value assessment of sofosbuvir-based regimens for (chronic) hepatitis C in Spain
International Liver CongresssTM 2021 (ILC) (EASL). 23-26 jun 2021

Martínez-Campreciós J, Domínguez-Hernández R, Marcos-Fosch C, Rando-Segura A, Riveiro-Barciela M, Rodríguez-Frías F, Casado MA, Esteban R, Buti M

 

Active search to retrieve lost-to follow-up HCV patients (RELINK-C strategy): health and economic value
International Liver CongresssTM 2021 (ILC) (EASL). 23-26 jun 2021

García F, Domínguez-Hernández R, Alados JC, Casado M, Macías J, Téllez F, Pascasio JM, Casado MA

 

 

Reflex testing in patients with chronic hepatitis C in Spain improves healthcare outcomes and is cost effective
The International Liver Congress™ 2019 de la European Association for the Study of the Liver (EASL). Viena (Austria) 14-19 abr 2019

Buti M, Domínguez-Hernández R, Casado MA, Sabater E, Esteban R

 

 

Screening and treatment of hepatitis C virus infection of adult general population in Spain is cost-effective
The international liver congressTM 2018. 53st Annual meeting of the European for the study of the liver (EASL). París, Francia. 11-15 abr 2018

Turnes J, Domínguez-Hernández R, Casado MA

 

 

 

Health outcomes and costs associated with the implementation of a national treatment plan for hepatitis C in Spain
68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). Washington, EEUU. 20-24 oct 2017